Find out why Cotempla XR-ODT is so hard to find in 2026, what's causing availability issues, and what you can do to get your prescription filled.
You've got the prescription in hand. Your child needs their ADHD medication. But pharmacy after pharmacy tells you the same thing: "We don't have Cotempla XR-ODT in stock."
It's frustrating, stressful, and unfortunately more common than it should be. If you've been searching for Cotempla XR-ODT (Methylphenidate extended-release orally disintegrating tablets) and coming up empty, this article explains why — and what you can do about it.
Cotempla XR-ODT is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17. It contains Methylphenidate, the same active ingredient found in medications like Concerta and Ritalin.
What makes Cotempla XR-ODT unique is its formulation: it's an orally disintegrating tablet that dissolves on the tongue without water. This makes it ideal for children who have difficulty swallowing pills. The tablet provides about 25% immediate-release and 75% extended-release Methylphenidate, offering symptom control throughout the school day.
It's available in three strengths: 8.6 mg, 17.3 mg, and 25.9 mg, and it's classified as a Schedule II controlled substance by the DEA.
Several factors work together to make Cotempla XR-ODT difficult to locate at your local pharmacy:
Cotempla XR-ODT is made exclusively by Neos Therapeutics. There is no generic version available. When a medication relies on a single manufacturer, any production delay, raw material shortage, or quality issue can ripple through the entire supply chain. Unlike drugs with multiple generic makers, there's no backup source for Cotempla XR-ODT.
Since late 2022, the United States has experienced a widespread shortage of ADHD stimulant medications. This shortage has affected both amphetamine-based and Methylphenidate-based drugs. The root causes include surging demand for ADHD medications (partly driven by increased diagnoses during and after the COVID-19 pandemic), DEA manufacturing quotas that limit how much active ingredient can be produced each year, and supply chain disruptions.
While Cotempla XR-ODT isn't always specifically listed on the FDA's shortage database, the ripple effects of the broader stimulant shortage mean pharmacies have trouble keeping niche formulations in stock.
Because Methylphenidate is a Schedule II controlled substance, the DEA sets annual limits on how much can be manufactured. These quotas are meant to prevent diversion and abuse, but they can also constrain supply when demand unexpectedly increases. Manufacturers must apply for quota increases, and the approval process doesn't always keep pace with real-world patient needs.
Most pharmacies stock medications based on demand. Because Cotempla XR-ODT is a specialty brand-name product with a relatively small patient population compared to generic Methylphenidate tablets, many pharmacies simply don't carry it regularly. Chain pharmacies in particular tend to prioritize high-volume generics, which means your local CVS or Walgreens may never have Cotempla XR-ODT on the shelf unless it's specifically ordered.
The good news is that there are practical steps you can take:
Medfinder helps patients locate medications that are hard to find. Instead of calling pharmacy after pharmacy, you can search for Cotempla XR-ODT availability in your area from one place.
Independent and compounding pharmacies often have more flexibility in ordering niche medications. They may have relationships with different wholesalers and can sometimes source brand-name drugs that chain pharmacies can't or won't stock.
Even if a pharmacy doesn't stock Cotempla XR-ODT regularly, most can place a special order through their wholesaler. Ask the pharmacist to order it — it typically arrives within 1-3 business days if it's available at the distribution level.
If you consistently can't find Cotempla XR-ODT, your prescriber may be able to switch to a similar medication. Options include Concerta (Methylphenidate ER tablets), Ritalin LA (Methylphenidate ER capsules that can be opened and sprinkled), or other long-acting ADHD medications. Read more in our guide to alternatives to Cotempla XR-ODT.
Don't wait until the last pill to start looking for a refill. Because Cotempla XR-ODT is a Schedule II controlled substance, prescriptions cannot be called in and refills require a new prescription each time. Start the refill process at least 7-10 days before you run out.
Finding Cotempla XR-ODT in 2026 can be genuinely difficult, but understanding the reasons behind the supply challenges can help you plan more effectively. Between the single-manufacturer situation, DEA quotas, and the ongoing ADHD medication landscape, this isn't a problem that will resolve overnight.
Your best tools are planning ahead, using resources like Medfinder, and maintaining open communication with your pharmacist and prescriber. You can also check our guide to finding Cotempla XR-ODT in stock for more practical tips.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
